What are the side effects of dasatinib?

Dasatinib, sold under the trade name Sprycel, is a BCR-ABL tyrosine kinase inhibitor commonly used to treat chronic myelogenous leukemia (CML). It mainly inhibits the activity of BCR-ABL tyrosine kinase and blocks the BCR-ABL signal transduction pathway, thereby inhibiting the proliferation and survival of leukemia cells and achieving the purpose of controlling the disease.

However, dasatinib may also cause a series of side effects during treatment. These side effects may vary from person to person and may not occur in all patients taking dasatinib. Common side effects include but are not limited to:

Myelosuppression is one of the common side effects of dasatinib, which may cause patients to experience symptoms such as anemia, leukopenia, and thrombocytopenia. These changes may increase a patient's risk of infection and may lead to bleeding tendencies. Therefore, while taking dasatinib, patients need to closely monitor blood routine in order to detect and deal with bone marrow suppression in a timely manner.

Gastrointestinal symptoms are also one of the common side effects of dasatinib. Patients may experience nausea, vomiting, diarrhea, stomach pain, or stomach upset. These symptoms may affect a patient's appetite and nutrient absorption, thereby affecting their overall health. Therefore, while taking dasatinib, patients need to maintain good eating habits and follow the doctor's recommendations for dietary adjustments.

In addition, some patients may also experience side effects of fluid retention, such as pleural effusion, pericardial effusion, or edema. These side effects may cause patients to experience symptoms such as chest tightness, shortness of breath, and difficulty breathing. In severe cases, fluid retention can also be life-threatening. Therefore, once these symptoms occur, patients should seek medical attention immediately and inform their doctor that they are taking dasatinib.

In addition to the above-mentioned side effects, dasatinib may also cause other adverse reactions, such as allergic reactions (rash, itching, skin redness and swelling, etc.), liver function damage, low phosphate levels, toxic epidermal necrolysis, tumor lysis syndrome, etc. Although these side effects are rare, if they occur, they may have a serious impact on the patient's health. Therefore, while taking dasatinib, patients need to pay close attention to their body's response and undergo regular examinations to evaluate the efficacy and safety of the drug.

It should be noted that the side effects of dasatinib are not inevitable, and most side effects can be relieved after stopping the drug or adjusting the dose. Therefore, while taking dasatinib, patients should follow their doctor's recommendations and communicate with their doctor regularly to evaluate the efficacy and safety of the drug. At the same time, patients should also maintain a good mentality and living habits to improve treatment effects and quality of life.